| Revenue | 13.33M |
| Cost of sales | 11.06M |
| Gross margin | 2.27M |
| Research and product development | 957K |
| Sales and marketing | 463K |
| General and administrative | 2.79M |
| Total operating expenses | 4.21M |
| Operating loss | -1.94M |
| Foreign exchange gain | 11K |
| Interest and other income | 145K |
| Interest and other expense | -874K |
| Net loss | -2.66M |
| Dividends on preferred stock | 302K |
| Net loss available to common stockholders, basic and diluted | |
| Net loss | -2.66M |
| Change in foreign currency translation adjustments | -8K |
| Comprehensive loss | -2.67M |
| Net loss per share available to common stockholders, basic and diluted (in Dollars per share) | -0.02 |
| Shares used in computing net loss per share available to common stockholders, basic and diluted (in Shares) | -325.97M |